B. Metzler seel. Sohn & Co. AG
Position in RDY — Dr Reddys Laboratories Ltd
CIK 1847838
FRANKFURT, 2M
Position in RDY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$5,061,967
+$221,173 QoQ
Shares Held
365,485
+6.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026B. Metzler seel. Sohn & Co. AG holds $26,269,777 across 6 Drug Manufacturers - Specialty & Generic names. RDY ranks #2 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
137,813 | $16,290,874 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
This page
|
365,485 | $5,061,967 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
64,130 | $1,931,595 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
64,698 | $1,548,223 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
5,962 | $785,433 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,099 | $651,685 |
All Filings in RDY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,061,967 | 365,485 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $4,840,794 | 344,786 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $476,005 | 34,049 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $511,756 | 34,049 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $449,106 | 34,049 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $537,633 | 34,049 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,997,373 | 25,140 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $2,273,966 | 29,846 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,189,204 | 29,846 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,302,819 | 33,096 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,213,129 | 33,096 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,972,269 | 62,942 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,884,155 | 33,096 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $1,712,718 | 33,096 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,503,885 | 28,733 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,591,520 | 28,733 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $837,733 | 15,032 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $1,216,233 | 18,594 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||